“…45 The engineering of the multilayer capsules allows the obtaining of multi-purpose systems serving as stimulus-responsive and controllable tools with a high biomedical potential to be used in the clinic, in particular, for cancer therapy and diagnosis. 11,45,46 The existing approaches to multilayering and encapsulation enable the effective entrapment of low-molecular-weight anticancer drugs (including doxorubicin, 38,47,48 5-fluorouracil, 49 curcumin, 42 thymoquinone, 50 and gemcitabine 46 ), and high-molecular-weight compounds, such as enzymes, 51 small interfering RNAs (siRNAs), 41,52 and antibodies, 53 as well as nanoparticles representing drug-adjuvant complexes, e.g., doxorubicin-bovine serum albumin (BSA) conjugates, 54 in multilayer containers.…”